Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial-Reference-Cited by-同舟云学术

Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial

Published:2012-07-06 Issue:10 Volume:51 Page:1894-1905
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

van der Heijde D.,Braun J.,Dougados M.,Sieper J.,Pedersen R.,Szumski A.,Koenig A. S.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/51/10/1894/5152584/kes142.pdf

Reference14 articles.

1. Ankylosing spondylitis

2. Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy

3. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study

4. ASAS/EULAR recommendations for the management of ankylosing spondylitis

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Foot involvement in psoriatic arthritis: Prevalence, clinical and radiological features;Foot and Ankle Surgery;2024-08

2. Korean treatment recommendations for patients with axial spondyloarthritis;The Korean Journal of Internal Medicine;2023-09-01

3. Korean treatment recommendations for patients with axial spondyloarthritis;Journal of Rheumatic Diseases;2023-07-01

4. The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?;Rheumatology;2022-10-07

5. Instrument selection for the ASAS core outcome set for axial spondyloarthritis;Annals of the Rheumatic Diseases;2022-06-09